Skip to main navigation Skip to search Skip to main content

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

  • E. J. M. Bertrums*
  • , C. M. Zwaan
  • , D. Hasegawa
  • , V. de Haas
  • , D. N. Reinhardt
  • , Franco Locatelli
  • , B. de Moerloose
  • , M. Dworzak
  • , A. Buijs
  • , P. Smisek
  • , A. Kolenova
  • , C. J. Pronk
  • , Klusmann J. -H.
  • , A. Carbone
  • , A. Ferster
  • , E. Antoniou
  • , S. Meshinchi
  • , S. C. Raimondi
  • , C. M. Niemeyer
  • , H. Hasle
  • M. M. van den Heuvel-Eibrink, B. F. Goemans
*Corresponding author
  • St. Luke's International Hospital
  • Princess Máxima Center for Pediatric Oncology
  • Ghent University
  • Medical University of Vienna
  • Utrecht University
  • Charles University
  • Comenius University
  • Queen Fabiola Children's University Hospital
  • University of Duisburg-Essen
  • Fred Hutchinson Cancer Research Center
  • Aarhus University

Research output: Contribution to journalArticle

Abstract

no abstract
Original languageEnglish
Pages (from-to)759-4764
Number of pages4006
JournalHaematologica
Volume107
Issue number3
DOIs
Publication statusPublished - 2022

All Science Journal Classification (ASJC) codes

  • Hematology

Keywords

  • myeloproliferative disease

Fingerprint

Dive into the research topics of 'Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS'. Together they form a unique fingerprint.

Cite this